• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Report sees solid refurbishing market

Article

Mountain View, CA, healthcare research firm Frost & Sullivan reported last month that the refurbished medical equipment market claimed revenues of more than $723.5 million in 1997, according to the firm's World Markets for

Mountain View, CA, healthcare research firm Frost & Sullivan reported last month that the refurbished medical equipment market claimed revenues of more than $723.5 million in 1997, according to the firm's World Markets for Reconditioned/Refurbished Diagnostic Imaging Equipment report. With managed care affecting healthcare costs, many small hospitals and private practices have acquired reconditioned or refurbished equipment.

Hospitals' efforts to eliminate superfluous services or to merge and downsize have resulted in a surplus of equipment in larger hospitals, according to Frost & Sullivan analysts. Although the surplus feeds the reconditioned/refurbished industry with a ready supply of used equipment, the industry continues to deal with its customers' quality-control demands, especially since the Food and Drug Administration has been under increased pressure to monitor the U.S. refurbished market. The current market is dominated by small, private companies, but if the FDA increases its scrutiny, these small companies may be required to partner with large manufacturers, the report states.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.